Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Plasmacytoma × Leukapheresis × Clear all

Sponsor

Conditions

Lymphoma, Non-Hodgkin 6 Multiple Myeloma 5 Lymphoma, Mantle-Cell 4 Lymphoma, Large B-Cell, Diffuse 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Follicular 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Myeloid, Acute 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Hodgkin Disease 3 Waldenstrom Macroglobulinemia 2 Sezary Syndrome 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, Extranodal NK-T-Cell 2 Lymphoma 2 Immunoblastic Lymphadenopathy 2 Burkitt Lymphoma 2 Breast Neoplasms 2 Recurrence 1 Ovarian Neoplasms 1 Neuroblastoma 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Lymphoma, T-Cell 1 Lymphoma, B-Cell 1

Interventions

Dexamethasone 3 dexamethasone acetate 2 dexamethasone 21-phosphate 2 auricularum 2 Calcium Dobesilate 2 Bortezomib 2 pomalidomide 1 navtemadlin; 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid 1 ixazomib 1 daratumumab 1 carfilzomib 1 Specimen Handling 1 Peripheral Blood Stem Cell Transplantation 1 Panobinostat 1 Melphalan 1 Lenalidomide 1 Gemcitabine 1 Busulfan 1 Biopsy 1 2-(5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-(1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡